United Therapeutics Corp
XNAS: UTHR
United Therapeutics Corp Live Stock Price Today, Share Analysis and Chart
about
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on...
Read More
454.00
6.55
(1.46%)
358.2K
XNAS Volume
XNAS 06 Nov, 2025 4:30 PM (EST)
Board Meeting
The next board meeting for United Therapeutics Corp is on 10 Nov 2025 for the purpose of UBS Global Healthcare Conference
See details
High Financial Strength
Mid Valuation
Technically Bullish
Strong Performer, Getting Expensive
These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying.
View Similar
Embed DVM
United Therapeutics Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..